GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (SZSE:002399) » Definitions » Cyclically Adjusted Book per Share

Shenzhen Hepalink Pharmaceutical Group Co (SZSE:002399) Cyclically Adjusted Book per Share : ¥7.30 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shenzhen Hepalink Pharmaceutical Group Co's adjusted book value per share for the three months ended in Mar. 2024 was ¥8.222. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥7.30 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Shenzhen Hepalink Pharmaceutical Group Co's average Cyclically Adjusted Book Growth Rate was 1.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shenzhen Hepalink Pharmaceutical Group Co was 3.70% per year. The lowest was 2.00% per year. And the median was 2.20% per year.

As of today (2024-06-09), Shenzhen Hepalink Pharmaceutical Group Co's current stock price is ¥9.67. Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥7.30. Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is 1.32.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 4.29. The lowest was 1.05. And the median was 2.47.


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.72 6.83 6.98 7.18 7.25

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.20 7.19 7.27 7.25 7.30

Competitive Comparison of Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio falls into.



Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shenzhen Hepalink Pharmaceutical Group Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=8.222/115.2271*115.2271
=8.222

Current CPI (Mar. 2024) = 115.2271.

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 6.161 98.200 7.229
201409 6.354 98.900 7.403
201412 6.459 99.000 7.518
201503 6.659 99.900 7.681
201506 6.551 99.500 7.586
201509 6.480 100.500 7.430
201512 6.810 100.600 7.800
201603 6.659 102.200 7.508
201606 6.296 101.400 7.155
201609 6.404 102.400 7.206
201612 6.391 102.600 7.178
201703 6.413 103.200 7.160
201706 6.029 103.100 6.738
201709 6.041 104.100 6.687
201712 6.236 104.500 6.876
201803 6.007 105.300 6.573
201806 6.121 104.900 6.724
201809 4.679 106.600 5.058
201812 4.890 106.500 5.291
201903 5.303 107.700 5.674
201906 5.267 107.700 5.635
201909 5.480 109.800 5.751
201912 5.892 111.200 6.105
202003 6.142 112.300 6.302
202006 6.216 110.400 6.488
202009 7.668 111.700 7.910
202012 7.885 111.500 8.149
202103 7.987 112.662 8.169
202106 7.923 111.769 8.168
202109 7.979 112.215 8.193
202112 7.777 113.108 7.923
202203 7.934 114.335 7.996
202206 8.202 114.558 8.250
202209 8.424 115.339 8.416
202212 8.391 115.116 8.399
202303 8.434 115.116 8.442
202306 8.449 114.558 8.498
202309 8.455 115.339 8.447
202312 8.119 114.781 8.151
202403 8.222 115.227 8.222

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Shenzhen Hepalink Pharmaceutical Group Co  (SZSE:002399) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=9.67/7.3
=1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 4.29. The lowest was 1.05. And the median was 2.47.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Hepalink Pharmaceutical Group Co (SZSE:002399) Business Description

Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business and Others. Geographical presence of company is in Hong Kong, United States of America, Europe, Mainland China and Other countries. Majority of the company's revenue comes from USA and Europe.
Executives
Zhang Ping Director
Li Li Director
Kong Yun Executives
Li Tan Directors, executives

Shenzhen Hepalink Pharmaceutical Group Co (SZSE:002399) Headlines

No Headlines